Hyperbilirubinemia in hospitalized patients: Etiology and outcomes

医学 内科学 黄疸 病因学 队列 胆红素 胃肠病学 恶性肿瘤 肝病 回顾性队列研究 原发性胆汁性肝硬化 贫血 儿科
作者
Joshua Kwon,Paul J. Nietert,Don C. Rockey
出处
期刊:Journal of Investigative Medicine [SAGE Publishing]
卷期号:71 (7): 773-781
标识
DOI:10.1177/10815589231180498
摘要

There is little information on the differential diagnosis and prognosis of hospitalized patients with hyperbilirubinemia. Here, we hypothesized that hyperbilirubinemia in hospitalized patients is associated with specific diseases and outcomes. This retrospective cohort analysis included patients admitted to the Medical University of South Carolina with a total bilirubin >3 mg/dL from January 9, 2015 to August 25, 2017. Collected clinical data included demographics, primary diagnosis, Charlson Comorbidity Index (CCI), laboratory data, and clinical outcomes. We separated and analyzed the cohort into seven primary diagnostic groups. We identified 1693 patients with a bilirubin level >3 mg/dL. The cohort was 42% female, had an average age of 54, average CCI of 4.8, and average length of stay of 13 days. The causes of hyperbilirubinemia included the following: primary liver disease (868/1693; 51%) with cirrhosis being most common (385/1693; 23%), benign biliary obstruction (252/1693; 15%), hemolytic anemia (149/1693; 9%), malignant biliary obstruction (121/1693; 7%), unknown etiology (108/1693; 6%), primary liver cancer (74/1693; 4%), and metastatic cancer to the liver (57/1693; 3%). Overall, the mortality/discharge to hospice rate in patients with a bilirubin >3 mg/dL was 30%, and was proportional to the severity of hyperbilirubinemia, including when controlling for the underlying severity of illness. Mortality was highest in patients with primary liver disease and malignancy and was lowest in patients with non-cancerous obstruction or hemolytic jaundice. Hyperbilirubinemia in hospitalized patients is most often due to primary liver disease, and identifies patients with a poor prognosis, particularly when caused by primary liver disease or cancer.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ottsannn完成签到,获得积分10
刚刚
大个应助蓦然回首采纳,获得10
刚刚
Dou_Xiaowen发布了新的文献求助10
1秒前
1秒前
baobaobaozi完成签到,获得积分20
1秒前
jyy应助包子采纳,获得10
2秒前
CodeCraft应助Cc采纳,获得10
3秒前
3秒前
4秒前
6秒前
黑风小妖完成签到,获得积分10
6秒前
7秒前
7秒前
hi应助爱偷懒的猪采纳,获得10
9秒前
星星完成签到,获得积分20
10秒前
大模型应助无情白羊采纳,获得10
10秒前
快乐滑板发布了新的文献求助10
10秒前
10秒前
永毅完成签到 ,获得积分10
10秒前
言亦云应助顺利的雁采纳,获得30
11秒前
豆花发布了新的文献求助50
11秒前
11秒前
hhhhhhhhh完成签到,获得积分10
12秒前
guoguo发布了新的文献求助10
12秒前
12秒前
隐形曼青应助杨乙友采纳,获得10
13秒前
13秒前
14秒前
15秒前
雨齐完成签到,获得积分10
16秒前
18秒前
18秒前
20秒前
传统的如霜完成签到,获得积分10
20秒前
鲨鱼牙齿发布了新的文献求助10
20秒前
20秒前
21秒前
21秒前
alverine发布了新的文献求助10
21秒前
爱偷懒的猪完成签到,获得积分10
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969557
求助须知:如何正确求助?哪些是违规求助? 3514377
关于积分的说明 11173836
捐赠科研通 3249692
什么是DOI,文献DOI怎么找? 1794979
邀请新用户注册赠送积分活动 875537
科研通“疑难数据库(出版商)”最低求助积分说明 804836